Mauro Delorenzi
Mauro Delorenzi
SIB Swiss Institute of Bioinformatics
Verified email at unil.ch
Title
Cited by
Cited by
Year
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective …
W De Roock, B Claes, D Bernasconi, J De Schutter, B Biesmans, ...
The lancet oncology 11 (8), 753-762, 2010
20482010
The consensus molecular subtypes of colorectal cancer
J Guinney, R Dienstmann, X Wang, A De Reyniès, A Schlicker, ...
Nature medicine 21 (11), 1350-1356, 2015
19752015
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ...
Journal of the National Cancer Institute 98 (4), 262-272, 2006
18742006
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
M Buyse, S Loi, L Van't Veer, G Viale, M Delorenzi, AM Glas, ...
Journal of the National Cancer Institute 98 (17), 1183-1192, 2006
13262006
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 …
AD Roth, S Tejpar, M Delorenzi, P Yan, R Fiocca, D Klingbiel, D Dietrich, ...
Journal of clinical oncology 28 (3), 466-474, 2010
10742010
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ...
Clinical cancer research 13 (11), 3207-3214, 2007
9842007
70-gene signature as an aid to treatment decisions in early-stage breast cancer
F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ...
New England Journal of Medicine 375 (8), 717-729, 2016
9462016
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
P Wirapati, C Sotiriou, S Kunkel, P Farmer, S Pradervand, B Haibe-Kains, ...
Breast Cancer Research 10 (4), R65, 2008
8652008
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade
S Loi, B Haibe-Kains, C Desmedt, F Lallemand, AM Tutt, C Gillet, P Ellis, ...
Journal of clinical oncology 25 (10), 1239, 2007
8332007
A comparison of methods for differential expression analysis of RNA-seq data
C Soneson, M Delorenzi
BMC bioinformatics 14 (1), 91, 2013
8142013
Identification of molecular apocrine breast tumours by microarray analysis
P Farmer, H Bonnefoi, V Becette, M Tubiana-Hulin, P Fumoleau, ...
Breast Cancer Research 7 (2), 1-1, 2005
8002005
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes
C Desmedt, B Haibe-Kains, P Wirapati, M Buyse, D Larsimont, ...
Clinical cancer research 14 (16), 5158-5165, 2008
7882008
Regional and cellular gene expression changes in human Huntington's disease brain
A Hodges, AD Strand, AK Aragaki, A Kuhn, T Sengstag, G Hughes, ...
Human molecular genetics 15 (6), 965-977, 2006
7042006
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
MaQC Consortium
Nature biotechnology 28 (8), 827, 2010
6712010
Stem cell-related" self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
A Murat, E Migliavacca, T Gorlia, WL Lambiv, T Shay, MF Hamou, ...
Journal of clinical oncology 26 (18), 3015-24, 2008
6442008
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
P Farmer, H Bonnefoi, P Anderle, D Cameron, P Wirapati, V Becette, ...
Nature medicine 15 (1), 68-74, 2009
5862009
Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
A Sistigu, T Yamazaki, E Vacchelli, K Chaba, DP Enot, J Adam, I Vitale, ...
Nature medicine 20 (11), 1301-1309, 2014
5542014
An HMM model for coiled-coil domains and a comparison with PSSM-based predictions
M Delorenzi, T Speed
Bioinformatics 18 (4), 617-625, 2002
4172002
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
E Missiaglia, B Jacobs, G D'ario, AF Di Narzo, C Soneson, E Budinska, ...
Annals of oncology 25 (10), 1995-2001, 2014
3712014
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
S Loi, B Haibe-Kains, C Desmedt, P Wirapati, F Lallemand, AM Tutt, ...
BMC genomics 9 (1), 239, 2008
3622008
The system can't perform the operation now. Try again later.
Articles 1–20